Pine Nuts - Insulin Resistance Diet / Satiety - References
Welcome To
SmartBodyz Nutrition
Your Online Source for Nutritional Supplements and Related Research![]()
Korean Pine Nuts - Insulin Resistance Diet / Satiety
(Stimulant Free)References:
1. Heilbronn LK, de JL, Frisard MI, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006 Apr 5;295(13):1539-48.2. Fontana L. Excessive adiposity, calorie restriction, and aging. JAMA. 2006 Apr 5;295(13):1577-8.
3. Calle EE, Kaaks R. Overweight: epidemiological evidence and proposed mechanisms. Nat Rev Canc. 2004 Aug;4(8):579-91.
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular mortality in middle-aged men. JAMA. 2002 Dec 4;288(21):2709-16.
5. Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging. Neural Plast. 2005;12(4):311-28.
6. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005 Aug 2;112(5):666-73.
7. Causey JL. Korean pine nut fatty acids induce satiety-producing hormone release in overweight human volunteers. Paper presented at: American Chemical Society National Meeting & Exposition; March 26-30, 2006; Atlanta, GA..
8. Manrique C, Lastra G, Whaley-Connell A, Sowers JR. Hypertension and the cardiometabolic syndrome. J Clin Hypertens. 2005 Aug;7(8):471-6.
9. Amling CL. Relationship between being overweight and prostate. Curr Opin Urol. 2005 May;15(3):167-71.
10. Haffner SM. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med. 2006 May;119(5 Suppl 1):S3-9.
11. Capeau J. Insulin signaling: mechanisms altered in insulin resistance. Med Sci (Paris). 2005 Dec;21 Spec No:34-9.
12. Home P. Contributions of basal and post-prandial hyperglycaemia to micro and macrovascular complications in people. Curr Med Res Opin. 2005 Jul;21(7):989-98.
13. Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R. Pulmonary complications in diabetes mellitus: the role of glycemic control. Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):455-8.
14. Lacquemant C, Vasseur F, Lepretre F, Froguel P. Adipocytokins, Overweight and development of type 2 diabetes. Med Sci (Paris). 2005 Dec;21 Spec No10-8.
15. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005 Aug;184(4):285-93.
16. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005 May;64(2):163-9.
17. Bhansali A, Dutta P. Pathophysiology of prediabetes. J Indian Med Assoc. 2005 Nov;103(11):594-5.
18. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006 May;119(5 Suppl 1):S10-6.
19. Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev. 2005 Nov;6(4):297-306.
20. Verdich C, Flint A, Gutzwiller JP, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab. 2001 Sep;86(9):4382-9.
21. Stoffers DA. The development of beta-cell mass: recent progress and potential role of GLP-1. Horm Metab Res. 2004 Nov-Dec;36(11-12):811-21.
22. Paquot N, Tappy L. Adipocytokines: links. Rev Med Liege. 2005 May;60(5-6):369-73.
23. Christophe J. Is there appetite after GLP-1 and PACAP? Ann NY Acad Sci. 1998 Dec 11;865:323-35.
24. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998 Feb 1;101(3):515-20.
25. Gutzwiller JP, Degen L, Matzinger D, Prestin S, Beglinger C. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R562-7.
26. Marx J. Cellular warriors at the battle of the bulge. Science. 2003 Feb 7;299(5608):846-9.
27. Brennan IM, Feltrin KL, Horowitz M, et al. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men. Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1477-85.
28. Naslund E, Barkeling B, King N, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11.
29. Schick RR, Schusdziarra V, Mossner J, et al. Effect of CCK on food intake in man: physiological or pharmacological effect? Z Gastroenterol. 1991 Feb;29(2):53-8.
30. Adam TC, Westerterp-Plantenga MS. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and overweight subjects. Br J Nutr. 2005 Jun;93(6):845-51.
31. Lieverse RJ, Jansen JB, Masclee AA, Lamers CB. Satiety effects of a physiological dose of cholecystokinin in humans. Gut. 1995 Feb;36(2):176-9.
32. Meier JJ, Gethmann A, Gotze O, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia. 2006 Mar;49(3):452-8.
33. Sugano M, Ikeda I, Wakamatsu K, Oka T. Influence of Korean pine (Pinus koraiensis)-seed oil containing cis-5,cis-9,cis-12-octadecatrienoic acid on polyunsaturated fatty acid metabolism, eicosanoid production and blood pressure of rats. Br J Nutr. 1994 Nov;72(5):775-83.
34. Lee JW, Lee KW, Lee SW, Kim IH, Rhee C. Selective increase in pinolenic acid (all-cis-5,9,12-18:3) in Korean pine nut oil by crystallization and its effect on LDL-receptor activity. Lipids. 2004 Apr;39(4):383-7.
Dosage and Use:
- To reduce meal size, take three softgels 30-60 minutes before the meal with the highest caloric content, or as recommended by a healthcare practitioner.
- To reduce snacking, you can take three softgels between meals.
- Do not exceed six softgels daily.
- The best time to use this product may be in the evening to reduce food intake before bedtime.
Side Effects: Appetite suppression
Warnings Information:
- Keep out of reach of children and pregnant and/or lactating women
- Do not exceed recommended dose
- If you have a bad reaction, discontinue use immediately
- When using Pine Nuts Appetite Suppressants, please inform your physician.
Special Sale! In addition to your 25% off, you get another 10% automatic volume discount at checkout on orders of $25 or more ... all items apply (including special sale items). SECURE SHOPPING CART CREDIT CARD PURCHASES ONLY. Call-ins do not receive this special discount.
Order: Korean Pine Nuts/Natural Appetite Control/Suppressant | San-Hoodia | Hoodia Gordonii Supreme | Original Lipodrene |
Hydroxycut | CLA w/Guarana | 5-HTP | All-In-One Weight Loss | Super Green Tea
or, send check, money order, or cashiers check with completed order form
|
Enjoy the benefits our flat rate shipping and handling! You receive the same great service for the same shipping price whether you order one item or one hundred! $5.95 Within
USA only - US Post Office
5-7 business days |
Save 8.25% on all purchases - Texans and everyone! It's all tax free! You will be able to review all charges before they are charged to you. At checkout (after you click the Add button above), the billing address you enter must match the address where you receive your credit card (security effects). The shipping address you enter does not have to match. All orders placed by Noon Central Standard Time (CST) are shipped the same day. PO Boxes Okay. Payment by credit card is immediate. Payment by check adds a few more business days -- as soon as funds clear. We do not sell the information you give us to anyone. |
Protecting
Your Personal Information: For additional information regarding the privacy of your sensitive cardholder data, please read the Authorize.Net Privacy Policy. |
|
SmartBodyz
Nutrition Home Page |
|
The
information and statements made throughout this web
site have not been endorsed/evaluated by the Food and Drug
Administration or any other governmental authority, unless otherwise
specifically noted. We
do not offer products or services for the benefits or purpose of diagnosis,
prescription for, treatment of, or claims to prevent, mitigate or cure
any viral or disease condition. |